Frappaz D, Barritault M, Montane L, Laigle-Donadey F, et al. MEVITEM - A Phase I/II of vismodegib + temozolomide vs temozolomide in patients with recurrent/refractory medulloblastoma with Sonic Hedgehog pathway activation. Neuro Oncol 2021 Apr 7. pii: 6213882. doi: 10.1093.
PMID: 33825892